A detailed history of 9258 Wealth Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, 9258 Wealth Management, LLC holds 17,396 shares of BMY stock, worth $925,293. This represents 0.11% of its overall portfolio holdings.

Number of Shares
17,396
Previous 20,198 13.87%
Holding current value
$925,293
Previous $1.1 Million 34.06%
% of portfolio
0.11%
Previous 0.17%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

SELL
$40.25 - $52.99 $112,780 - $148,477
-2,802 Reduced 13.87%
17,396 $722,000
Q1 2024

May 03, 2024

SELL
$47.98 - $54.4 $17,176 - $19,475
-358 Reduced 1.74%
20,198 $1.1 Million
Q4 2023

Feb 06, 2024

SELL
$48.48 - $57.85 $72,477 - $86,485
-1,495 Reduced 6.78%
20,556 $1.05 Million
Q3 2023

Nov 08, 2023

SELL
$57.89 - $64.73 $29,350 - $32,818
-507 Reduced 2.25%
22,051 $1.28 Million
Q2 2023

Aug 08, 2023

SELL
$63.71 - $70.74 $16,883 - $18,746
-265 Reduced 1.16%
22,558 $1.44 Million
Q1 2023

May 03, 2023

BUY
$65.71 - $74.53 $38,440 - $43,600
585 Added 2.63%
22,823 $1.58 Million
Q4 2022

Feb 03, 2023

SELL
$68.48 - $81.09 $98,268 - $116,364
-1,435 Reduced 6.06%
22,238 $1.6 Million
Q3 2022

Nov 08, 2022

SELL
$0.13 - $76.84 $168 - $99,815
-1,299 Reduced 5.2%
23,673 $1.68 Million
Q2 2022

Aug 04, 2022

SELL
$72.62 - $79.98 $72,983 - $80,379
-1,005 Reduced 3.87%
24,972 $1.92 Million
Q1 2022

May 13, 2022

BUY
$61.48 - $73.72 $8,176 - $9,804
133 Added 0.51%
25,977 $1.9 Million
Q4 2021

Feb 11, 2022

SELL
$53.63 - $62.52 $50,197 - $58,518
-936 Reduced 3.5%
25,844 $1.61 Million
Q3 2021

Nov 12, 2021

SELL
$59.17 - $69.31 $42,365 - $49,625
-716 Reduced 2.6%
26,780 $1.59 Million
Q2 2021

Aug 13, 2021

BUY
$61.91 - $67.42 $23,773 - $25,889
384 Added 1.42%
27,496 $1.84 Million
Q1 2021

May 11, 2021

BUY
$59.34 - $66.74 $92,273 - $103,780
1,555 Added 6.08%
27,112 $1.71 Million
Q4 2020

Feb 10, 2021

BUY
$57.74 - $65.43 $175,356 - $198,710
3,037 Added 13.49%
25,557 $1.59 Million
Q3 2020

Nov 13, 2020

BUY
$57.43 - $63.64 $51,744 - $57,339
901 Added 4.17%
22,520 $1.32 Million
Q2 2020

Aug 13, 2020

BUY
$54.82 - $64.09 $21,982 - $25,700
401 Added 1.89%
21,619 $1.27 Million
Q1 2020

May 05, 2020

BUY
$46.4 - $67.43 $64,681 - $93,997
1,394 Added 7.03%
21,218 $1.33 Million
Q4 2019

Feb 06, 2020

BUY
$49.21 - $64.19 $94,433 - $123,180
1,919 Added 10.72%
19,824 $1.27 Million
Q3 2019

Nov 07, 2019

BUY
$42.77 - $50.71 $113,083 - $134,077
2,644 Added 17.33%
17,905 $908,000
Q2 2019

Aug 07, 2019

BUY
$44.62 - $49.34 $290,386 - $321,104
6,508 Added 74.35%
15,261 $692,000
Q1 2019

May 07, 2019

BUY
$45.12 - $53.8 $60,235 - $71,823
1,335 Added 18.0%
8,753 $418,000
Q4 2018

Feb 12, 2019

BUY
$48.76 - $63.23 $361,701 - $469,040
7,418 New
7,418 $386,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track 9258 Wealth Management, LLC Portfolio

Follow 9258 Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 9258 Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 9258 Wealth Management, LLC with notifications on news.